Synergy between 677 TT MTHFR genotype and related folate SNPs regulates homocysteine level

Nutrition Research

Volumn 26, Issue 4, 2006, Pages 180-185

  Lucock, Mark ^a   Yates, Zoe ^a  

^a UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

B vitamins; Cobalamin; Folate; Glutathione; Homocysteine; Polymorphism

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CYSTEINE; FOLIC ACID; GLUTATHIONE; HOMOCYSTEINE;

ALLELE; AMINO ACID ANALYSIS; AMINO ACID BLOOD LEVEL; AMINO ACID SUBSTITUTION; ANALYSIS OF VARIANCE; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FOLATE METABOLISM; GENE INTERACTION; GENE MUTATION; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MEDICAL ASSESSMENT; PRIORITY JOURNAL; PROTEIN METHYLATION; SINGLE NUCLEOTIDE POLYMORPHISM; VARIANCE;

EID: 33744807729     PISSN: 02715317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nutres.2006.01.001     Document Type: Article

References (23)

1. Guenther B.D., Sheppard C.A., Tran P., Rozen R., Matthews R.G., and Ludwig M. The structure and properties of methylenetetrahydrofolate reductase from E. coli suggest how folate ameliorates human hyperhomocysteinemia. Nat Struct Biol 6 (1999) 359-365
2. Boushey C.J., Beresford S.A., Omenn G.S., and Motulsky A.G. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 274 (1995) 1049-1057
3. Frosst P., Blom H.J., Milos R., Goyette P., Sheppard C.A., Matthews R.G., et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10 (1995) 111-113
4. Skibola C.F., Smith M.T., Kane E., Roman E., Rollinson S., Cartwright R.A., et al. Polymorphisms in the methylenetetrahydrofolate reductase gene are associated with susceptibility to acute leukemia in adults. Proc Natl Acad Sci U S A 96 (1999) 12810-12815
5. Slattery M.L., Potter J.D., Samowitz W., Schaffer D., and Leppert M. Methylenetetrahydrofolate reductase, diet, and risk of colon cancer. Cancer Epidemiol Biomark Prev 8 (1999) 513-518
6. Sohn K.J., Croxford R., Yates Z., Lucock M., and Kim Y.I. The effect of the methylenetetrahydrofolate reductase C677T polymorphism on chemosensitivity of colon and breast cancer cells to 5-fluorouracil and methotrexate. J Natl Cancer Inst 96 (2004) 134-144
7. Ma J., Stampfer M.J., Giovannucci E., Artigas C., Hunter D.J., Fuchs C., et al. Methylenetetrahydrofolate reductase polymorphism, dietary interactions and risk of colorectal cancer. Cancer Res 57 (1997) 1098-1102
8. Lucock M.D., and Yates Z. A differential role for folate in developmental disorders, vascular disease and other clinical conditions: the importance of folate status and genotype. In: Massaro E.J. (Ed). Chapter in folate and human development (2001), Humana Press, Totowa (NJ) 263-298
9. James S.J., Pogribna M., Pogribny I.P., Melnyk S., Hine R.J., Gibson J.B., et al. Abnormal folate metabolism and mutation in the methylenetetrahydrofolate reductase gene may be maternal risk factors for Down's syndrome. Am J Clin Nutr 70 (1999) 495-501
10. Mills J.L., Kirke P.N., Molloy A.M., Burke H., Conley M.R., Lee J., et al. Methylenetetrahydrofolate reductase thermolabile variant and oral cleft. Am J Med Genet 86 (1999) 71-74
11. Van der Put N.M.J., Steegers-Theunissen R.P.M., Frosst P., Trijbels F.J.M., Eskes T.K.A.B., Van der Heuvel L.P., et al. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet 346 (1995) 1070
12. Eskes T.K. Homocysteine and human reproduction. Clin Exp Obstet Gynecol 27 (2000) 157-167
13. Lucock M., Yates Z., Glanville T., Leeming R., Simpson R., and Daskalakis I. A critical role for B-vitamin nutrition in human developmental and evolutionary biology. Nutr Res 23 (2003) 1463-1475
14. Muller M., and Kersten S. Nutrigenomics: goals and strategies. Nat Rev Genet 4 (2003) 315-322
15. Lucock M., Daskalakis I., Hinkins M., and Yates Z. An examination of polymorphic genes and folate metabolism in mothers affected by a spina bifida pregnancy. Mol Genet Metab 73 (2001) 322-332
16. Van der Put N.M.J., Van der Molen E.F., Kluijtmans L.A.J., Heil S.G., Trijbels J.M.F., Eskes T.K.A.B., et al. Sequence analysis of the coding region of human methionine synthase: relevance to hyperhomocysteinaemia in NTD and vascular disease. Q J Med 90 (1997) 511-517
17. 12) increases risk for spina bifida. Mol Genet Metab 67 (1999) 317-323
18. Van der Put N.M., Gabreels F., Stevens E.M., Smeitink J.A., Trijbels F.J., Eskes T.K., et al. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural tube defects?. Am J Hum Genet 62 (1998) 1044-1051
19. Winkelmayer W.C., Eberle C., Sunder-Plassmann G., and Fodinger M. Effects of the glutamate carboxypeptidase II (GCP2 1561C>T) and reduced folate carrier (RFC1 80G>A) allelic variants on folate and total homocysteine levels in kidney transplant patients. Kidney Int 63 (2003) 2280-2285
20. Daskalakis I., Lucock M.D., Anderson A., Wild J., Schorah C.J., and Levene M.I. Determination of plasma total homocysteine and cysteine using HPLC with fluorescence detection and an ammonium 7-fluoro-2,1,3-benzoxadiazole-4-sulphonate (SBDF-) derivitization protocol optimised for antioxidant concentration, derivitization reagent concentration, temperature and matrix pH. Biomed Chromatogr 10 (1996) 205-212
21. Lucock M.D., Wild J., Smithells R., and Hartley R. In vivo characterisation of the absorption and biotransformation of pteroylglutamic acid in man: a model for future studies. Biochem Med Metab Biol 42 (1989) 30-42
22. Lucock M. Clinical review science, medicine, and the future: is folic acid the ultimate functional food component for disease prevention?. BMJ 328 (2004) 211-214
23. Mosharov E., Cranford M.R., and Banerjee R. The quantitatively important relationship between homocysteine metabolism and glutathione synthesis by the transsulfuration pathway and its regulation by redox changes. Biochemistry 39 (2000) 13005-13011